Current status and future of liver transplantation

Seminars in Liver Disease

Volumn 30, Issue 4, 2010, Pages 411-421

  Merion, Robert M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

deceased organ donation; indications; Liver transplantation; living donor liver transplant; surgical technique; waiting list

Indexed keywords

BILE DUCT ATRESIA; CADAVER DONOR; CHRONIC LIVER DISEASE; CLINICAL EVALUATION; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT; LIVER NECROSIS; LIVER TRANSPLANTATION; LIVING DONOR; METABOLIC DISORDER; MORTALITY; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

BODY DYSMORPHIC DISORDERS; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; HEPATITIS C, CHRONIC; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS;

EID: 77958155198     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0030-1267541     Document Type: Review

References (127)

1. Starzl T E., Groth C G., Brettschneider L et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968 168 (3) 392-415
2. Starzl T E., Marchioro T L., Vonkaulla K N., Hermann G, Brittain R S., Waddell W R. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963 117 659-676
3. Starzl T E., Fung J J. Themes of liver transplantation. Hepatology 2010 51 (6) 1869-1884
4. Calne R Y., Rolles K, White D J. et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979 2 (8151) 1033-1036
5. Millard C E. The NIH Consensus Development Conference on liver transplantation. R I Med J 1984 67 (2) 69-71
6. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 19982007. Rockville, MD U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation 2009
7. Thuluvath P J., Guidinger M K., Fung J J., Johnson L B., Rayhill S C., Pelletier S J. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010 10 (4 Pt 2) 1003-1019
8. Perrillo R. Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: a survey of North American, European, and Asian-Pacific transplant programs. Liver Transpl 2009 15 (2) 223-232
9. Fan S T., Cheung S T., Lo C M. Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma. J Gastroenterol Hepatol 2000 15 (Suppl) E181-E186
10. Xiao L, Fu Z R., Ding G S. et al. Liver transplantation for hepatitis B virus-related hepatocellular carcinoma: one center's experience in China. Transplant Proc 2009 41 (5) 1717-1721
11. Lo C M., Fan S T., Liu C L., Lai C L., Wong J. Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Transplantation 2003 75 (3, Suppl) S41-S44 (Pubitemid 36222988)
12. Gerhardt T C., Goldstein R M., Urschel H C. et al. Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation 1996 62 (8) 1060-1063
13. Krom R A. Liver transplantation and alcohol: who should get transplants? Hepatology 1994 20 (1 Pt 2) 28S-32S
14. Beresford T P., Turcotte J G., Merion R et al. A rational approach to liver transplantation for the alcoholic patient. Psychosomatics 1990 31 (3) 241-254
15. Lucey M R., Merion R M., Henley K S. et al. Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 1992 102 (5) 1736-1741
16. Snyder S L., Drooker M, Strain J J. A survey estimate of academic liver transplant teams' selection practices for alcohol-dependent applicants. Psychosomatics 1996 37 (5) 432-437
17. Weinrieb R M., Van Horn D H., McLellan A T., Lucey M R. Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl 2000 6 (6) 769-776
18. DiMartini A, Day N, Dew M A. et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006 12 (5) 813-820
19. DiMartini A, Day N, Dew M A. et al. Alcohol use following liver transplantation: a comparison of follow-up methods. Psychosomatics 2001 42 (1) 55-62
20. Tringali R A., Trzepacz P T., DiMartini A, Dew M A. Assessment and follow-up of alcohol-dependent liver transplantation patients. A clinical cohort. Gen Hosp Psychiatry 1996 18 (6, Suppl) 70S-77S
21. Campbell D A. Jr, Magee J C., Punch J D., Merion R M., Turcotte J G., Bromberg J S. One center's experience with liver transplantation: alcohol use relapse over the long-term. Liver Transpl Surg 1998 4 (5, Suppl 1) S58-S64
22. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334 (11) 693-699
23. D'Amico F, Schwartz M, Vitale A et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl 2009 15 (10) 1278-1287
24. Mazzaferro V, Llovet J M., Miceli R et al, Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009 10 (1) 35-43
25. Yao F Y. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant 2008 8 (10) 1982-1989
26. Fan S T. Selection of HCC patients for liver transplantation: the Milan criteria, Hangzhou criteria and beyond. Hepatobiliary Pancreat Dis Int 2008 7 (3) 233-234
27. Volk M, Marrero J A. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology 2008 134 (5) 1612-1614
28. Volk M L., Vijan S, Marrero J A. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008 8 (4) 839-846
29. Yao F Y., Ferrell L, Bass N M. et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001 33 (6) 1394-1403
30. Lo C. Downstaging of hepatocellular carcinoma before transplantation: an advance in therapy or just another selection criterion. Am J Transplant 2008 8 (12) 2485-2486
31. Heimbach J K. Liver transplantation for hepatocellular carcinoma. Cancer J 2008 14 (2) 95-99
32. Freeman R Jr.B. Transplantation for hepatocellular carcinoma: the Milan criteria and beyond. Liver Transpl 2006 12 (11, Suppl 2) S8-S13
33. Otto G, Herber S, Heise M et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006 12 (8) 1260-1267
34. Yao F Y., Hirose R, LaBerge J M. et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005 11 (12) 1505-1514
35. Yao F Y., Kerlan R K. Jr, Hirose R et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008 48 (3) 819-827
36. Pomfret E A., Washburn K, Wald C et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010 16 (3) 262-278
37. de Alwis N M., Day C P. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008 48 (Suppl 1) S104-S112
38. Burke A, Lucey M R. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004 4 (5) 686-693
39. Grambsch P M., Dickson E R., Wiesner R H., Langworthy A. Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. Mayo Clin Proc 1989 64 (6) 699-704 (Pubitemid 19197644)
40. Abu-Elmagd K M., Malinchoc M, Dickson E R. et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993 177 (4) 335-344
41. Brandsaeter B, Isoniemi H, Broomé U et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004 40 (5) 815-822
42. Kim W R., Poterucha J J., Wiesner R H. et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999 29 (6) 1643-1648
43. Ricci P, Therneau T M., Malinchoc M et al. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 1997 25 (3) 672-677
44. Talwalkar J A., Seaberg E, Kim W R., Wiesner R H., National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. Liver Transpl 2000 6 (6) 753-758
45. Baerg J, Zuppan C, Klooster M. Biliary atresiaa fifteen-year review of clinical and pathologic factors associated with liver transplantation. J Pediatr Surg 2004 39 (6) 800-803
46. Prabhakran K. Biliary atresia: Kasai and liver transplantation. Ann Acad Med Singapore 1991 20 (4) 540-542
47. Burdelski M, Rogiers X. Liver transplantation in metabolic disorders. Acta Gastroenterol Belg 1999 62 (3) 300-305
48. Kayler L K., Merion R M., Lee S et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002 6 (4) 295-300
49. Kayler L K., Rasmussen C S., Dykstra D M. et al. Liver transplantation in children with metabolic disorders in the United States. Am J Transplant 2003 3 (3) 334-339
50. Pratschke J, Steinmüller T, Bechstein W O. et al. Orthotopic liver transplantation for hepatic associated metabolic disorders. Clin Transplant 1998 12 (3) 228-232
51. Gruessner R W. Preemptive liver transplantation from a living related donor for primary hyperoxaluria type I. N Engl J Med 1998 338 (26) 1924
52. Jamieson N V., European PHI Transplantation Study Group. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004. Am J Nephrol 2005 25 (3) 282-289
53. Jamieson N V. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol 1998 11 (Suppl 1) 36-41
54. Jamieson N V. The European Primary Hyperoxaluria Type 1 Transplant Registry report on the results of combined liver/kidney transplantation for primary hyperoxaluria 1984-1994. European PH1 Transplantation Study Group. Nephrol Dial Transplant 1995 10 (Suppl 8) 33-37
55. Liou I W., Larson A M. Role of liver transplantation in acute liver failure. Semin Liver Dis 2008 28 (2) 201-209
56. Renner E L. How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King's College criteria, or something else? J Hepatol 2007 46 (4) 554-557
57. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004 40 (2) 192-197
58. McCashland T M., Shaw B W. Jr, Tape E. The American experience with transplantation for acute liver failure. Semin Liver Dis 1996 16 (4) 427-433
59. Bismuth H, Samuel D, Castaing D, Williams R, Pereira S P. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996 16 (4) 415-425 (Pubitemid 27074783)
60. Mirza D F., Mohamed R, Mutimer D J., McMaster P. Timing and candidacy for transplantation in acute liver failure: the European experience. Liver Transpl Surg 1995 1 (3) 182-186
61. Chapman R W., Forman D, Peto R, Smallwood R. Liver transplantation for acute hepatic failure? Lancet 1990 335 (8680) 32-35
62. Lee W M., Hynan L S., Rossaro L et al, Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009 137 (3) 856-864, 864, e1
63. Foley D P., Collins B R., Magee J C. et al. Bile acids in xenogeneic ex-vivo liver perfusion: function of xenoperfused livers and compatibility with human bile salts and porcine livers. Transplantation 2000 69 (2) 242-248
64. Sussman N L., Kelly J H. Extracorporeal liver support: cell-based therapy for the failing liver. Am J Kidney Dis 1997 30 (5, Suppl 4) S66-S71
65. National Vital Statistics System. Available at: http://www.cdc.gov/nchs/ nvss.htm Accessed July 21, 2010
66. Mathur A K., Sonnenday C J., Merion R M. Race and ethnicity in access to and outcomes of liver transplantation: a critical literature review. Am J Transplant 2009 9 (12) 2662-2668
67. Mathur A K., Schaubel D E., Gong Q, Guidinger M K., Merion R M. Racial and ethnic disparities in access to liver transplantation. Liver Transpl 2010 16 1033-1040
68. Brockmann J G., Vaidya A, Reddy S, Friend P J. Retrieval of abdominal organs for transplantation. Br J Surg 2006 93 (2) 133-146
69. Abu-Elmagd K, Fung J, Bueno J et al. Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann Surg 2000 232 (5) 680-687
70. Ackermann J R., Snell M E. Cadaveric renal transplantation: a technique for donor kidney removal. Br J Urol 1968 40 (5) 515-521
71. Starzl T E., Miller C, Broznick B, Makowka L. An improved technique for multiple organ harvesting. Surg Gynecol Obstet 1987 165 (4) 343-348
72. Rosenthal J T., Shaw B W. Jr, Hardesty R L., Griffith B P., Starzl T E., Hakala T R. Principles of multiple organ procurement from cadaver donors. Ann Surg 1983 198 (5) 617-621
73. Renz J F., Yersiz H, Reichert P R. et al. Split-liver transplantation: a review. Am J Transplant 2003 3 (11) 1323-1335
74. Zamir G, Olthoff K M., Desai N, Markmann J F., Shaked A. Toward further expansion of the organ pool for adult liver recipients: splitting the cadaveric liver into right and left lobes. Transplantation 2002 74 (12) 1757-1761
75. Azoulay D, Castaing D, Adam R et al. Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg 2001 233 (4) 565-574
76. Reyes J, Gerber D, Mazariegos G V. et al. Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg 2000 35 (2) 283-289 discussion 289-290
77. Busuttil R W., Goss J A. Split liver transplantation. Ann Surg 1999 229 (3) 313-321
78. Rogiers X, Malagó M, Gawad K et al. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg 1996 224 (3) 331-339 discussion 339-341
79. Emond J C., Whitington P F., Broelsch C E. Overview of reduced-size liver transplantation. Clin Transplant 1991 5 (2 part 2) 168-173
80. Humar A, Ramcharan T, Sielaff T D. et al. Split liver transplantation for two adult recipients: an initial experience. Am J Transplant 2001 1 (4) 366-372
81. Englesbe M J., Merion R M. The riskiest job in medicine: transplant surgeons and organ procurement travel. Am J Transplant 2009 9 (10) 2406-2415
82. Englesbe M J., Shah S, Cutler J A. et al, Michigan Donor Travel Forum. Improving organ procurement travel practices in the United States: proceedings from the Michigan Donor Travel Forum. Am J Transplant 2010 10 (3) 458-463
83. Loinaz C, González E M. Marginal donors in liver transplantation. Hepatogastroenterology 2000 47 (31) 256-263
84. Totsuka E, Fung J J., Ishii T et al. Influence of donor condition on postoperative graft survival and function in human liver transplantation. Transplant Proc 2000 32 (2) 322-326
85. Yersiz H, Shaked A, Olthoff K et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995 60 (8) 790-794
86. Feng S, Goodrich N P., Bragg-Gresham J L. et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006 6 (4) 783-790
87. Merion R M., Pelletier S J., Goodrich N, Englesbe M J., Delmonico F L. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006 244 (4) 555-562
88. D'alessandro A M., Hoffmann R M., Knechtle S J. et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000 128 (4) 579-588
89. Skaro A I., Jay C L., Baker T B. et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery 2009 146 (4) 543-552 discussion 552-553
90. Gibbons R D., Duan N, Meltzer D. Inequities in liver transplant allocation. Science 2000 289 (5479) 549-550
91. Keeffe E B. Summary of guidelines on organ allocation and patient listing for liver transplantation. Liver Transpl Surg 1998 4 (5, Suppl 1) S108-S114
92. Neuberger J, Adams D, MacMaster P, Maidment A, Speed M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ 1998 317 (7152) 172-175
93. Delmonico F L., Jenkins R L., Freeman R et al. The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg 1992 127 (5) 579-584
94. Starzl T E., Gordon R D., Tzakis A et al. Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc 1988 20 (1) 131-138
95. Committee on Organ Procurement and Transplantation Policy. Organ procurement and transplantation: assessing current policies and the potential impact of the DHHS final rule. Washington, DC National Academies Press 1999
96. Malinchoc M, Kamath P S., Gordon F D., Peine C J., Rank J, ter Borg P C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000 31 (4) 864-871
97. Wiesner R, Edwards E, Freeman R et al, United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003 124 (1) 91-96
98. Wiesner R H., McDiarmid S V., Kamath P S. et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001 7 (7) 567-580
99. Edwards E B., Harper A M. The impact of MELD on OPTN liver allocation: preliminary results. Clin Transpl 2002 21-28
100. McDiarmid S V., Anand R, Lindblad A S., Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002 74 (2) 173-181
101. Davies D B. The impact of PELD on OPTN liver allocation: preliminary results. Clin Transpl 2003 13-20
102. McDiarmid S V., Goodrich N P., Harper A M., Merion R M. Liver transplantation for status 1: the consequences of good intentions. Liver Transpl 2007 13 (5) 699-707
103. Organ Procurement and Transplantation Network. Policy 3.6. Allocation of deceased livers. Available at: http://www.optn.org/PoliciesandBylaws/policies/ pdfs/policy-8.pdf Accessed August 3, 2006
104. Sharma P, Balan V, Hernandez J L. et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004 10 (1) 36-41
105. Washburn K, Edwards E, Harper A, Freeman R. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010 10 (7) 1643-1648
106. Freeman R B. Jr, Gish R G., Harper A et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006 12 (12, Suppl 3) S128-S136
107. Schaubel D E., Guidinger M K., Biggins S W. et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009 9 (4 Pt 2) 970-981
108. Biggins S W., Kim W R., Terrault N A. et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006 130 (6) 1652-1660
109. Kim W R., Biggins S W., Kremers W K. et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008 359 (10) 1018-1026
110. Merion R M., Schaubel D E., Dykstra D M., Freeman R B., Port F K., Wolfe R A. The survival benefit of liver transplantation. Am J Transplant 2005 5 (2) 307-313
111. Pomfret E A., Fryer J P., Sima C S., Lake J R., Merion R M. Liver and intestine transplantation in the United States, 1996-2005. Am J Transplant 2007 7 (5 Pt 2) 1376-1389
112. Schaubel D E., Sima C S., Goodrich N P., Feng S, Merion R M. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008 8 (2) 419-425
113. Samuel D, Feray C. Recurrence of hepatitis C virus infection after liver transplantation. J Hepatol 1999 31 (Suppl 1) 217-221
114. Terrault N A. Hepatitis C therapy before and after liver transplantation. Liver Transpl 2008 14 (Suppl 2) S58-S66
115. Xirouchakis E, Triantos C, Manousou P et al. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. J Viral Hepat 2008 15 (10) 699-709
116. Everson G T., Kulig C C. Antiviral therapy for hepatitis C in the setting of liver transplantation. Curr Treat Options Gastroenterol 2006 9 (6) 520-529
117. Houben K W., McCall J L. Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transpl Surg 1999 5 (2) 91-95
118. Whitington P F. Living donor liver transplantation: ethical considerations. J Hepatol 1996 24 (5) 625-627
119. Piper J B., Whitington P F., Woodle E S., Newell K A., Alonso E M., Thistlethwaite J R. Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago. Transpl Int 1994 7 (Suppl 1) S111-S113
120. Roberts J P., Hulbert-Shearon T E., Merion R M., Wolfe R A., Port F K. Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant 2004 4 (3) 373-377
121. Lo C M., Fan S T., Liu C L. et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997 226 (3) 261-269 discussion 269-270
122. Marcos A, Fisher R A., Ham J M. et al. Right lobe living donor liver transplantation. Transplantation 1999 68 (6) 798-803
123. Trotter J F., Wachs M, Everson G T., Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002 346 (14) 1074-1082
124. Olthoff K M., Merion R M., Ghobrial R M. et al, A2ALL Study Group. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005 242 (3) 314-323 discussion 323-325
125. Ghobrial R M., Freise C E., Trotter J F. et al, A2ALL Study Group. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008 135 (2) 468-476
126. Berg C L., Gillespie B W., Merion R M. et al, A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007 133 (6) 1806-1813
127. Trotter J F., Adam R, Lo C M., Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006 12 (10) 1485-1488